New study aims to boost HIV prevention in black women facing violence
NCT ID NCT06703060
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a program to help Black women in Baltimore start taking PrEP, a medication that prevents HIV. The program addresses challenges like intimate partner violence and racism that can make it hard to get PrEP. About 300 Black women who are HIV-negative and at risk will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Johns Hopkins Bloomberg School of Public Health
RECRUITINGBaltimore, Maryland, 21205, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Phone-Based Self-Compassion program ease trauma for chinese immigrant women?
- Can supportive laws shield LGBTQ+ youth from violence?
- A structured education program may ease recovery after hysterectomy — a trial puts it to the test
- Could greek yogurt help Post-Menopausal women build muscle and control blood sugar?
- Can a conversation prevent HIV? study tests In-Person vs. online counseling for PrEP uptake
- Pharmacy-Based PrEP could transform HIV prevention for young women in tanzania